BOT 1.59% 32.0¢ botanix pharmaceuticals ltd

Ann: Updated Investor Presentation, page-41

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,956 Posts.
    lightbulb Created with Sketch. 79
    Yup, the CBD/Permetrex combination is what they have patented for skin diseases:

    "Medical dermatology company Botanix Pharmaceuticals Limited (“Botanix” or “The Company”) today announced that it has filed 5 new patent applications covering Permetrex enabled products.The new patent applications include additional uses for the Company’s drug active, synthetic cannabidiol in different skin diseases outside acne, as well as additional products targeted at complementary skin care. Permetrex is the delivery technology utilised for the Company’s lead acne treatment, BTX-1503, which is progressing rapidly through clinical development. The new patent applications were filed simultaneously in the US and Australia."

    https://www.botanixpharma.com/wp-content/uploads/17-02-27-BOT-Files-New-Product-Patents-.pdf

    Last edited by refresher: 04/03/19
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
32.0¢
Change
0.005(1.59%)
Mkt cap ! $707.4M
Open High Low Value Volume
31.5¢ 32.5¢ 31.0¢ $1.169M 3.655M

Buyers (Bids)

No. Vol. Price($)
9 274982 31.5¢
 

Sellers (Offers)

Price($) Vol. No.
32.0¢ 48600 2
View Market Depth
Last trade - 16.10pm 22/11/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.